[Clinical characteristics of seizure-predominant autoimmune encephalitis and utility of anti-neuronal antibody scores for early treatment].

Q4 Medicine
Clinical Neurology Pub Date : 2024-04-24 Epub Date: 2024-03-20 DOI:10.5692/clinicalneurol.cn-001911
Masanobu Tanemoto, Syuuichirou Suzuki, Kazuki Yokokawa, Taro Saito, Naotoshi Iwahara, Reiko Tsuda, Osamu Watanabe, Yukitoshi Takahashi, Makoto Yoneda, Shin Hisahara
{"title":"[Clinical characteristics of seizure-predominant autoimmune encephalitis and utility of anti-neuronal antibody scores for early treatment].","authors":"Masanobu Tanemoto, Syuuichirou Suzuki, Kazuki Yokokawa, Taro Saito, Naotoshi Iwahara, Reiko Tsuda, Osamu Watanabe, Yukitoshi Takahashi, Makoto Yoneda, Shin Hisahara","doi":"10.5692/clinicalneurol.cn-001911","DOIUrl":null,"url":null,"abstract":"<p><p>We analyzed 20 patients diagnosed with autoimmune neurological diseases with seizure predominance. In these patients, we examined the usefulness of Antibody Prevalence in Epilepsy and Encephalopathy (APE<sup>2</sup>) score and Antibodies Contributing to Focal Epilepsy Signs and Symptoms (ACES) score in autoimmune encephalitis (AE) for facilitating early treatment. APE<sup>2</sup> score was positive in 19 of 20 patients. ACES score was positive in 15 of 20 patients, and 4 of 5 of the patients with negative ACES score did not have AE. Comprehensive assessment including the use of the above scores is desirable in the early stage of AE.</p>","PeriodicalId":39292,"journal":{"name":"Clinical Neurology","volume":" ","pages":"272-279"},"PeriodicalIF":0.0000,"publicationDate":"2024-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Neurology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5692/clinicalneurol.cn-001911","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/3/20 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

We analyzed 20 patients diagnosed with autoimmune neurological diseases with seizure predominance. In these patients, we examined the usefulness of Antibody Prevalence in Epilepsy and Encephalopathy (APE2) score and Antibodies Contributing to Focal Epilepsy Signs and Symptoms (ACES) score in autoimmune encephalitis (AE) for facilitating early treatment. APE2 score was positive in 19 of 20 patients. ACES score was positive in 15 of 20 patients, and 4 of 5 of the patients with negative ACES score did not have AE. Comprehensive assessment including the use of the above scores is desirable in the early stage of AE.

[以癫痫发作为主的自身免疫性脑炎的临床特征和抗神经元抗体评分对早期治疗的作用]。
我们分析了 20 名被诊断为以癫痫发作为主的自身免疫性神经疾病患者。在这些患者中,我们研究了自身免疫性脑炎(AE)中癫痫和脑病抗体流行率(APE2)评分和局灶性癫痫体征和症状抗体(ACES)评分对促进早期治疗的作用。20 名患者中有 19 人的 APE2 评分呈阳性。在 20 名患者中,有 15 名患者的 ACES 评分呈阳性,而在 ACES 评分呈阴性的 5 名患者中,有 4 名患者未患自身免疫性脑炎。在 AE 的早期阶段,最好进行包括上述评分在内的综合评估。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Clinical Neurology
Clinical Neurology Medicine-Neurology (clinical)
CiteScore
0.30
自引率
0.00%
发文量
147
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信